Life ScienceCompany
Biogen M&A Summary
Biogen has acquired 10 companies, including 4 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Biogen’s largest acquisition to date was in 2023, when it acquired Reata Pharmaceuticals for $7.3B. It’s largest disclosed sale occurred in 2019, when it sold Biogen - Biologics Manufacturing Site to FUJIFILM Holdings for $890M. Biogen has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
Biogen Business Overview
Where is Biogen headquartered?
Biogen is headquartered in Cambridge, Massachusetts.
What is Biogen’s revenue?
Biogen disclosed revenue of 9,836M USD for 2023 and 10,173M USD for 2022.
How many employees does Biogen have?
Biogen has 7,570 employees.
What sector is Biogen in?
Biogen is a life science company.
When was Biogen founded?
Biogen was founded in 1978.
M&A Summary
-
M&A Total Activity10
- M&A Buy Activity9
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 4
Unlimited Searches
